Breast cancer survivors' participation in social activities five years after primary surgery - are there social inequalities? [0.03%]
乳腺癌术后五年生存者参与社会活动的差异？
Stefanie Sperlich,Siegfried Geyer,Sophia Holthausen-Markou et al.
Stefanie Sperlich et al.
Background: To date, the social participation of breast cancer survivors has mainly been studied in terms of their return to work, while long-term studies on participation in social activities are rare. Against this backd...
Multicenter Study
BMC cancer. 2025 Nov 27;25(1):1829. DOI:10.1186/s12885-025-15297-0 2025
Secular trend of colorectal cancer related with low physical activity from 1990 to 2021 in China [0.03%]
1990至2021年中国结直肠癌的长期低身体活动流行趋势分析
Qian Yang,Yao Hu,Fang Liu
Qian Yang
Objective: This study aims to report low physical activity related colorectal cancer (LPARCC) death and Disability Adjusted Life Years (DALYs) in 1990-2021, and decompose the changes in disease burden into population grow...
Trend analysis of cancer mortality and years of life lost in the South of Iran 2004-2019. Joinpoint regression analysis [0.03%]
2004-2019年伊朗南部癌症死亡率及生命损失年的 joinpoint回归分析趋势研究
Habibollah Azarbakhsh,Fatemeh Rezaei,Seyed Parsa Dehghani et al.
Habibollah Azarbakhsh et al.
Background: Cancer is the second leading cause of death globally and is a significant financial burden on public health systems. This study aimed to investigate cancer mortality trends and years of life lost (YLL) in Fars...
Phase IV international prospective validation of the EORTC patient satisfaction core questionnaire (EORTC PATSAT-C33) and outpatient module (EORTC OUT-PATSAT7) [0.03%]
欧洲癌症研究与治疗组织患者满意度核心问卷（EORTC Patsat-C33）和门诊模块（EORTC Out-Patsat7）的国际前瞻性四期验证研究报告
Anne Brédart,Jean-Luc Kop,Omar Shamieh et al.
Anne Brédart et al.
Background: Advances in cancer care require ongoing monitoring of patient satisfaction using rigorous questionnaires. The EORTC Quality of Life Group has cross-culturally developed a patient satisfaction core questionnair...
Multicenter Study
BMC cancer. 2025 Nov 26;25(1):1824. DOI:10.1186/s12885-025-15119-3 2025
Status of and factors influencing paternal fatigue in children with retinoblastoma: a cross-sectional study [0.03%]
视网膜母细胞瘤患儿父亲疲乏状况及其影响因素：横断面研究
Shanshan Xiong,Na Du,Yanan He et al.
Shanshan Xiong et al.
The role of indocyanine green in the intraoperative navigation of gastric cancer surgery: a systematic review and meta-analysis [0.03%]
吲哚菁绿在胃癌手术期间导航作用的系统评价和网络 meta 分析
Nassuf Mourdi,Yongke Wu,Yuanhao Su et al.
Nassuf Mourdi et al.
MDM2-amplified esophageal adenocarcinomas exhibit an activated metabolic and immunosuppressive phenotype with multiple potential therapeutic targets [0.03%]
MDM2扩增的食管腺癌具有激活的代谢和免疫抑制表型及多个潜在治疗靶点
Karl Knipper,Christiane J Bruns,Felix C Popp et al.
Karl Knipper et al.
Background: A complete response following neoadjuvant therapy occurs only in a fraction of patients with esophageal adenocarcinoma (EAC). Further targeted treatment options are needed to improve treatment response and pat...
Proteomics of malignant pleural mesothelioma under hypoxic and normoxic conditions in a large animal (porcine) tumor model [0.03%]
低氧和常氧条件下恶性胸膜间皮瘤的蛋白质组学研究——大型动物（猪）肿瘤模型中的作用
Weirun Min,Donggang He,Xuanbo Liu et al.
Weirun Min et al.
Background: Malignant Pleural Mesothelioma (MPM) is a rare but highly aggressive malignant tumor, whose occurrence is closely associated with asbestos exposure. Clinical treatment options are limited and the prognosis is ...
Reducing breast biopsy at MRI: comparison of minimum ADC cutoff and mean ADC cutoff identified by the ECOG-ACRIN A6702 multicenter trial [0.03%]
基于ECOG-ACRIN A6702多中心试验的DWI检查乳腺活检中最小ADC阈值与平均ADC阈值的比较研究
Fang Wu,Fangyi Xu,Jie He et al.
Fang Wu et al.
Background: The aim of this study was to validate the generalisability of the ECOG-ACRIN A6702 multicenter trial identified mean apparent diffusion coefficient (ADC) cutoff (1.53 × 10- 3mm2/s) and compare its biopsy redu...
Nanoencapsulation of ferrocene incorporated thiourea and doxorubicin for treatment of acute myeloid leukemia [0.03%]
用于治疗急性髓系白血病的含硫脲和多柔比星的菲克森纳米胶囊化
Nimra Idrees,Nosheen Fatima Rana,Urooba Tariq et al.
Nimra Idrees et al.